Stay updated on Durvalumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The government funding operating status notice was removed from the page. The rest of the study history and related content remains unchanged.
    Difference
    0.5%
    Check dated 2025-11-17T06:48:43.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new version entry (23) was added to the record history on 2022-02-23. It updates the Study Status and related documentation.
    Difference
    0.1%
    Check dated 2025-11-03T01:15:12.000Z thumbnail image
  4. Check
    48 days ago
    Change Detected
    Summary
    Updated operating status notice and version to v3.2.0; removes previous v3.1.0 reference and directs users to current status sources.
    Difference
    11%
    Check dated 2025-10-05T09:53:59.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Updated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new release version.
    Difference
    0.3%
    Check dated 2025-09-28T03:11:42.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Version updated to v3.0.2 (replacing v3.0.1) and the Back to Top element has been removed.
    Difference
    0.6%
    Check dated 2025-09-13T17:05:49.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-06T14:34:58.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Resectable NSCLC Clinical Trial page.